艾昆纬-自信而专注地创新-通过利用新的工具和方法,提高设计、规划和试验交付的可预测性和质量(英)

White PaperInnovating with Confidence and Focus Enhance predictability and quality in design, planning and trial delivery by leveraging novel tools and approachesRAJA SHANKAR, VP, Machine Learning, IQVIA STEPHEN HAMPTON, Director, Enterprise Architecture – Generative AI, IQVIAPart 2 of a 4-part series highlighting key innovations in clinical researchTable of contentsThe foundations of confidence: preparation and predictability 3The evolution towards prescriptive analytics 3More confident choices: key innovations in planning and design 4Advancements in clinical development planning 5Incorporating IQVIA Healthcare-grade AI® into pre-clinical analysis 5I. Understanding the asset’s properties and clinical landscape 5II. AI-powered insights to drive protocol optimization 6III. Rapidly generating scenarios for enrollment strategies 7IV. Accelerating site startup with targeted regulatory intelligence 8Looking ahead: the increasing role of agentic AI 8Conclusion 8About the authors 9 iqvia.com/rds | 3“With more advanced, cutting-edge technologies and tools increasingly available to better inform decisions, sponsors and their CRO partners can enhance the predictability of success and quality across design, planning and trial management.”Life involves risk, there’s no getting around it. In every aspect of our lives — whether it’s buying a car, starting a new career or making an investment, there is always a chance that things may not turn out as expected. To navigate successfully through our daily lives, we must prepare for unforeseen events and have contingency planning in place. The more informed our choices, the more likely we are to succeed.Similarly, in today’s rapidly-evolving clinical research ecosystem, safeguarding against risk through careful planning and management remains the cornerstone of successful design and delivery — ensuring the safety of trial participants, protecting data quality, achieving milestones in a timely fashion, optimizing patient recruitment and retention, and enhancing end-to-end efficiencies.And today, with highly advanced, cutting-edge technologies and tools increasingly available to better inform decisions, sponsors and their CRO partners can enhance the predictability of success and quality across design, planning and trial management — more so than ever before.This paper provides an overview of some key areas of innovation and technologies that are empowering better decision-making in early planning, design and across the clinical development continuum. By judiciously leveraging these advancements — in combination with improved data generation, expertise and domain experience — sponsors and CROs can have greater confidence in harnessing innovation to achieve better outcomes in their clinical trial programs.The evolution towards prescriptive analyticsBefore exploring specific methods being used to improve clinical trial predictability, it’s important to consider the evolution of advanced analytics in clinical trials

立即下载
综合
2025-06-25
10页
1.05M
收藏
分享

艾昆纬-自信而专注地创新-通过利用新的工具和方法,提高设计、规划和试验交付的可预测性和质量(英),点击即可下载。报告格式为PDF,大小1.05M,页数10页,欢迎下载。

本报告共10页,只提供前10页预览,清晰完整版报告请下载后查看,喜欢就下载吧!
立即下载
本报告共10页,只提供前10页预览,清晰完整版报告请下载后查看,喜欢就下载吧!
立即下载
水滴研报所有报告均是客户上传分享,仅供网友学习交流,未经上传用户书面授权,请勿作商用。
相关图表
表 3 多贴标科创债发行情况
综合
2025-06-25
来源:科创债2.0时代的亮点:政策、风险分担工具、产品创新
查看原文
表 2 科创债 2.0 时代“第二支箭”支持科创债发行情况
综合
2025-06-25
来源:科创债2.0时代的亮点:政策、风险分担工具、产品创新
查看原文
图 3 民营企业债券融资支持工具(“第二支箭”)发展历程
综合
2025-06-25
来源:科创债2.0时代的亮点:政策、风险分担工具、产品创新
查看原文
表 1 银行间非金融企业科创债发行主体要求
综合
2025-06-25
来源:科创债2.0时代的亮点:政策、风险分担工具、产品创新
查看原文
图 2 银行间非金融企业科创债 2.0 发行政策对比
综合
2025-06-25
来源:科创债2.0时代的亮点:政策、风险分担工具、产品创新
查看原文
驱动更高绩效的平台团队活动 驱动更高绩效的平台团队活动 若平台团队执行以下活动,组织实现高绩效的可能性增幅
综合
2025-06-25
来源:产品赋能平台实现成功产品管理的三大要素
查看原文
回顶部
报告群
公众号
小程序
在线客服
收起